Home health ops · Multi-line home care platform
CareVoyant
CareVoyant is a cloud home care and home health platform covering intake, authorization, scheduling, clinical documentation, eMAR/eTAR, EVV, and billing across private duty, PDN, personal care, HCBS, and home health on one patient record. It is not a hospital EHR.
Strong fit
- Agencies running private duty, PDN, personal care, and home health on one patient record
- Operators measuring authorization leakage, EVV exceptions, and clean claims
- Mid-market agencies that need eMAR/eTAR tied to scheduling and billing
Weak fit
- Enterprise post-acute chains standardized on WellSky or Homecare Homebase scale platforms
- Buyers who will not consolidate multi-line intake into one system
- Groups seeking only a standalone EVV app
Bottom line
CareVoyant earns a Recommend for multi-line home care agencies that want one clinical and billing system of record. The product story centers on shared patient and employee records across private duty, PDN, HCBS, and home health with EVV and revenue cycle in the same stack. Public dollar pricing is not posted. Score sits below Axxess and KanTime on brand scale while fitting the mid-market multi-line agency job cleanly.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
CareVoyant is a cloud platform for home care and home health agencies covering intake, authorization, scheduling, clinical documentation, eMAR/eTAR, EVV, and billing across multiple service lines on one patient record.
It is agency ops software, not a hospital EHR. Compare Axxess when brand scale and hospice depth matter more, and AxisCare when private-duty scheduling is the center of gravity.
Score reflects a credible mid-market multi-line fit with ordinary pricing opacity.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| CareVoyant | 7.0 | 6.8 |
| Axxess | 7.9 | 7.5 |
| KanTime | 7.6 | 7.3 |
| AxisCare | 7.5 | 7.2 |
| Careficient | 6.8 | 6.6 |
| Alora | 7.2 | 7.0 |
Pricing
| Item | Detail |
|---|---|
| Model | Cloud home care and home health software sold by agency size and modules; quote-based. |
| What usually drives cost | Users, patients, service lines, EVV footprint, and billing complexity. |
| What to ask in diligence | All-in monthly cost at your census and service-line mix, including EVV and eMAR modules. |
| Published pricing | Public list price: not published. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get CareVoyant to function | |
| Inventory of service lines and payer authorizations | Multi-line agencies break on auth rules. |
| EVV state requirements documented | Wrong EVV setup blocks payment. |
| Named clinical and billing cutover owners | Agency cutovers fail without both. |
| Clean patient and employee master lists | Duplicate records poison scheduling. |
| Device plan for field clinicians | POC apps fail without offline or connectivity plans. |
| What will maximize your value | |
| Pilot one service line before full multi-line cutover | Big-bang multi-line is risky. |
| Measure authorization leakage and clean-claim rate weekly | Ops metrics beat demos. |
| Train schedulers on travel-time and match rules | Bad matches create missed visits. |
| Retire legacy billing exports after parallel claims week | Dual billing creates denials. |
| Confirm eMAR/eTAR workflows with nursing leadership | Med errors become survey findings. |
| Deal-breakers | |
| You only need a standalone EVV app. | |
| Service lines and auth rules are undefined. | |
| No clinical or billing owner for cutover. | |
| You will not migrate patient masters. | |
| Leadership expects zero schedule change. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Contract signed → kickoff | 2-4 weeks |
| 2 | Kickoff → first live service line | 8-16 weeks |
| 3 | First live line → steady multi-line value | 3-6 months |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.